Rupatadine is a second-generation antihistamine with selective peripheral H1-receptor antagonist activity.
Desloratadine, one of the metabolites of rupatadine, may partially contribute to the overall efficacy of the drug.
The recommended dose of Rupafin in adults is one 10mg tablet daily, taken with or without food. Rupafin is not recommended for use in children under 12 years or patients with renal or hepatic impairment. It should be used with caution in elderly patients.
Further information: GlaxoSmithKline